Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
BGB-15025 by BeiGene for Non-Small Cell Lung Cancer: Likelihood of Approval
BGB-15025 is under clinical development by BeiGene and currently in Phase I for Non-Small Cell Lung Cancer. According to GlobalData,...
BGB-15025 by BeiGene for Gastric Cancer: Likelihood of Approval
BGB-15025 is under clinical development by BeiGene and currently in Phase I for Gastric Cancer. According to GlobalData, Phase I...
BGB-15025 by BeiGene for Solid Tumor: Likelihood of Approval
BGB-15025 is under clinical development by BeiGene and currently in Phase I for Solid Tumor. According to GlobalData, Phase I...
BGB-15025 by BeiGene for Gastroesophageal (GE) Junction Carcinomas: Likelihood of Approval
BGB-15025 is under clinical development by BeiGene and currently in Phase I for Gastroesophageal (GE) Junction Carcinomas. According to GlobalData,...
BGB-15025 by BeiGene for Esophageal Cancer: Likelihood of Approval
BGB-15025 is under clinical development by BeiGene and currently in Phase I for Esophageal Cancer. According to GlobalData, Phase I...